NZMS signs exclusive distribution agreement with Valeritas
Posted Apr 18, 2018.
NZMS are pleased to announce they have signed an exclusive distribution agreement with Valeritas Holdings, Inc. to market their V-Go® Wearable Insulin Delivery device, for patients with type 2 diabetes, in New Zealand.
“Adding V-Go® to our portfolio is a significant step towards addressing the needs of New Zealand patients with type 2 diabetes who want simple and effective insulin management that doesn’t interfere with their way of life,” said Richard Plowright, Managing Director of NZMS. “We’re delighted with our exclusive partnership with Valeritas, and we’re looking forward to seeing the benefits it will bring to patients across New Zealand.”